The COVID-19 pandemic is of particular concern for cancer patients, whose immune systems may be compromised due to their disease or treatment. During this challenging time, we are committed to sharing resources and insight that may be helpful in caring
for cancer patients.
Please bookmark this page, and check back often, as resources and guidance may evolve or be added.
Webcast Series: What Oncologists Need to Know Today
How is the COVID-19 pandemic specifically affecting cancer care, and what do clinicians need to know today to ensure they are providing the best care to their patients with cancer? Join the discussion on this fast-moving topic.
Presented by Physician Education Resource, LLC. View the archive of webcasts, including week 4, which features Dana-Farber's Toni Choueiri, MD.
If you are a physician caring for patients with hematologic malignancies, COVID-HEME is a peer-to-peer online forum started by hematologist/oncologists, including Dana-Farber physicians. COVID-HEME aims to improve and accelerate physicians’ knowledge
to optimize the management of patients during the COVID-19 pandemic. COVID-HEME is for physicians only.
COVID-HEME allows physicians to:
- Share observations, experiences, clinical practice, and resources
- Ask and answer questions related to patients with heme malignancies affected by COVID-19
The forum is accessible on computers, smartphones, and tablets.
Sign up at: https://covid-heme.trydiscourse.com
Use invite code: COVID-19-EARLYBIRDS
Suggested Treatment Modifications in Multidisciplinary Breast Cancer Management in the Setting of COVID-19
In response to the COVID-19 pandemic, the Breast Oncology team at Dana-Faber/Brigham and Women's Cancer Center has developed suggested treatment modifications for patients with breast cancer intended to minimize exposure while ensuring that patients
still receive life-sustaining care.
Stem Cell Transplant
Webinar: Caring for Stem Cell Transplant Patients During COVID-19
Presenters: Vincent Ho, MD; Amy Joyce, NP; Sarah Hammond, MD
Information current as of April 9, 2020
Patients who have had a stem cell transplant are especially vulnerable to the COVID-19 pandemic. Special precautions are needed for this at-risk population. During this webinar, we covered how to:
- Monitor patients for COVID-19 symptoms
- Know when to test for COVID-19 after transplant
- Recognize COVID-19 symptoms in immune-compromised patients
- Manage transplant complications
- Understand when a patient requires inpatient care
- Treat transplant side effects and COVID-19 simultaneously
Keeping Patients Safe
Please note: We have taken many steps to keep our patients safe during their visits to Dana-Farber, and to support them
during this time.